The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
1
|
V | Various | |
2
|
V04 | Diagnostic agents | |
3
|
V04C | Other diagnostic agents | |
4
|
V04CX | Other diagnostic agents | |
5
|
V04CX13 |
| Active Ingredient |
|---|
|
Pegulicianine is a prodrug that is optically inactive when intact and produces a fluorescent signal after its peptide chain is cleaved by cathepsins and matrix metalloproteases (MMPs). The levels of these enzymes are higher in and around tumor and tumor-associated cells than normal cells. Pegulicianine is indicated for fluorescence imaging in adults with breast cancer as an adjunct for the intraoperative detection of cancerous tissue within the resection cavity following removal of the primary specimen during lumpectomy surgery. |
| Document | Type | Information Source | |
|---|---|---|---|
| LUMISIGHT Solution for injection | MPI, US: SPL/PLR | FDA, National Drug Code (US) |